Platinum- and non-platinum-based regimens compared in NSCLC

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1288, 2001-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platinum- vs nonplatinum-based therapy in NSCLC

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Gemcitabine + vinorelbine: superior to platinum-based regimens in NSCLC?

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT Gu Jian Wu Xifeng

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Combination chemotherapy regimens compared in NSCLC

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Influence of polymorphisms in MTHFR 677 C→→T, TYMS 3R→→2R and MTR 2756 A→→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC

By Cui Lian-Hua Yu Zhuang Zhang Ting-Ting Shin Min-Ho Kim Hee-Nam Choi Jin-Su

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 797-808

Future Medicine

Access to resources Recommend Favorite